Durham, N.C.-based Bioventus has launched a new allograft substitute product, Osteoamp Select Flowable, the company said July 13.
The Osteoamp Select is optimal for minimally invasive surgeries and can be used in procedures such as lumbar spine fusion, cervical spine fusion and foot and ankle fusion, as well as for patients with expandable or 3D-printed cages, according to a company news release. Bioventus introduced the product in select U.S. markets in March.
"Spine, trauma and foot and ankle surgeons are looking for allograft options that handle well for a variety of procedures," Bioventus Product Development Vice President Larry Boyd, PhD, said in the release. "Developed by our team in collaboration with our tissue bank partner, Osteoamp Select Flowable comes ready to use and is designed to be delivered in a range of methods, and to provide excellent retention characteristics at the grafting site."
Paul Kim, MD, of Carolina Neurosurgery & Spine Associates, praised Bioventus' Osteoamp product line, saying he has seen "firsthand the successful patient outcomes it can help provide."
Bioventus is a medical device company offering products focused on pain treatment, joint preservation, restorative therapies and bone graft substitutes, among other things.